MedPath

Calcipotriol

Generic Name
Calcipotriol
Brand Names
Calcitrene, Dovobet, Dovonex, Enstilar, Sorilux, Taclonex, Wynzora
Drug Type
Small Molecule
Chemical Formula
C27H40O3
CAS Number
112965-21-6
Unique Ingredient Identifier
143NQ3779B
Background

Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.

Indication

For the treatment of moderate plaque psoriasis in adults.

Associated Conditions
Plaque psoriasis of the scalp, Psoriasis Vulgaris (Plaque Psoriasis)
Clinical Trials
Related News

PSOREAL - Managing PSOriasis in the REAL World

Completed
Conditions
Psoriasis Vulgaris
Interventions
Drug: Other topical
First Posted Date
2016-10-17
Last Posted Date
2021-06-14
Lead Sponsor
LEO Pharma
Target Recruit Count
1214
Registration Number
NCT02935582
Locations
🇸🇪

Psoriasis association in Stockholm region, Stockholm, Sweden

🇨🇦

Dr. Chih-Ho Hong Medical Inc., Surrey, British Columbia, Canada

🇬🇧

Layton Medical Centre, Blackpool, Lancashire, United Kingdom

Efficacy and Tolerability of Enstilar® in Daily Practice

Completed
Conditions
Plaque Psoriasis
Interventions
First Posted Date
2016-08-29
Last Posted Date
2019-12-13
Lead Sponsor
LEO Pharma
Target Recruit Count
410
Registration Number
NCT02881346
Locations
🇩🇪

Clinic for Dermatology, Venereology and Allergy, University Clinic Schleswig-Holstein, Kiel, Germany

Adherence in Topical Treatment of Psoriasis

Phase 4
Completed
Conditions
Adherence
Interventions
Device: App
First Posted Date
2016-08-08
Last Posted Date
2019-06-03
Lead Sponsor
Odense University Hospital
Target Recruit Count
134
Registration Number
NCT02858713
Locations
🇩🇰

Department of Dermatology and Allergy Centre, Odense C, Denmark

A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris.

First Posted Date
2016-04-12
Last Posted Date
2016-04-14
Lead Sponsor
First Hospital of China Medical University
Target Recruit Count
240
Registration Number
NCT02733874

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

Phase 1
Withdrawn
Conditions
Scleroderma
Interventions
First Posted Date
2016-02-11
Last Posted Date
2018-07-18
Lead Sponsor
Medical College of Wisconsin
Registration Number
NCT02680717

LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis

Phase 3
Completed
Conditions
Psoriasis Vulgaris
Interventions
Drug: LEO 80185 gel
First Posted Date
2016-01-29
Last Posted Date
2025-03-10
Lead Sponsor
LEO Pharma
Target Recruit Count
213
Registration Number
NCT02668692
Locations
🇯🇵

Medical Corporation Bikyukai Kokubu Dermatology, Kitami-shi, Hokkaido, Japan

Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis

Phase 3
Conditions
Psoriasis
Interventions
Drug: Placebo
Drug: Topical Coal tar
First Posted Date
2016-01-01
Last Posted Date
2016-01-01
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Target Recruit Count
40
Registration Number
NCT02644954

Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis

Phase 3
Completed
Conditions
Nail Psoriasis
Interventions
Drug: Vehicle of P-3073
First Posted Date
2015-11-17
Last Posted Date
2018-03-08
Lead Sponsor
Polichem S.A.
Target Recruit Count
378
Registration Number
NCT02606760

A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)

Phase 2
Completed
Conditions
Skin and Connective Tissue Diseases
Interventions
Drug: Aerosol spray vehicle
Drug: LP0113 aerosol spray
Drug: LEO 90100 aerosol foam
Drug: Daivobet® gel
First Posted Date
2015-04-14
Last Posted Date
2025-02-24
Lead Sponsor
LEO Pharma
Target Recruit Count
50
Registration Number
NCT02416258
Locations
🇫🇷

Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), Nice, France

Molecular Effects of Topical Calcipotriene on Morphea

Early Phase 1
Terminated
Conditions
Morphea
Localized Scleroderma
Interventions
First Posted Date
2015-04-08
Last Posted Date
2018-09-13
Lead Sponsor
Northwestern University
Target Recruit Count
2
Registration Number
NCT02411643
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy